ricin
toxin
classifi
biolog
threat
agent
center
diseas
control
prevent
extrem
toxic
eas
procur
castor
bean
absenc
avail
continu
concern
ricin
underscor
recent
nato
biomed
advisori
council
report
rank
ricin
top
list
agent
weapon
ricin
kda
heterodimer
glycoprotein
consist
subunit
rta
rtb
join
via
singl
disulfid
bond
rtb
amino
acid
residu
bival
lectin
recogn
galactos
gal
galactosamin
galnac
promot
ricin
attach
membran
bound
glycoprotein
glycolipid
mammalian
cell
rtb
also
facilit
transport
ricin
plasma
membran
network
tgn
endoplasm
reticulum
er
rta
liber
rtb
transloc
cytoplasm
rta
amino
acid
residu
catalyz
hydrolysi
sarcinricin
loop
ribosom
rna
therebi
arrest
protein
synthesi
trigger
program
cell
death
addit
exogen
lactos
inhibit
attach
host
cell
pathway
refer
ricin
also
gain
entri
certain
cell
type
pathway
first
describ
bone
macrophag
bdmc
later
shown
exist
kupffer
cell
kc
liver
sinusoid
endotheli
cell
lsec
ricin
mannosyl
differ
asparagin
residu
rta
posit
rtb
posit
number
studi
implic
mannos
receptor
mr
respons
ricin
uptak
bdmc
kc
lsec
although
studi
conduct
year
full
suit
lectin
ctl
role
pathogen
recognit
nonetheless
pathway
highli
effici
rout
ricin
enter
kill
kc
lsec
due
part
increas
rate
intern
compar
uptak
report
sought
revisit
sensit
kc
lsec
ricin
light
effort
develop
therapi
prophylact
ricin
exampl
recent
demonstr
iv
deliveri
singl
mab
direct
rta
abl
rescu
rhesu
macaqu
lethal
dose
aerosol
challeng
administ
within
h
model
ricin
intox
larg
restrict
lung
littl
system
contrast
follow
inject
ricin
home
liver
concentr
kc
roch
colleagu
report
mous
model
protect
mab
benefici
blunt
liver
damag
follow
ricin
exposur
although
specif
interact
kc
lsec
investig
lsec
particular
interest
regard
consid
import
scaveng
mannosyl
protein
coupl
central
role
promot
clearanc
small
immun
complex
sic
ricin
toxin
ricinu
communi
agglutinin
ii
purchas
vector
laboratori
burlingam
ca
dialyz
remov
sodium
azid
nativ
rta
r
communi
seed
obtain
bei
resourc
catalog
manassa
va
hepe
buffer
consist
gl
kcl
gl
nacl
gl
gl
gl
hepe
gl
phenol
red
distil
water
gey
balanc
salt
solut
gbss
contain
g
gl
kcl
gl
gl
gl
gl
nacl
gl
gl
gl
distil
water
mac
buffer
consist
wv
bsa
mm
edta
pb
without
mg
thermo
fisher
waltham
stainingwash
buffer
swb
flow
cytometri
contain
vv
fb
thermo
fisher
pb
mab
use
studi
shown
supplement
tabl
mab
purifi
hybridoma
supernat
protein
chromatographi
dana
farber
cancer
institut
dfci
monoclon
antibodi
core
facil
boston
murin
mab
rta
rtb
previous
vhh
rta
rtb
also
describ
except
manuscript
prepar
macrophag
cell
line
origin
obtain
dr
philip
stahl
washington
univers
school
medicin
st
loui
mo
cultur
dmem
contain
vv
fb
use
passag
number
primari
kc
cultur
medium
compris
dmem
vv
fb
uml
penicillin
streptomycin
mm
insulin
isol
purifi
lsec
cultur
medium
contain
vv
mcdb
media
st
loui
mo
fb
uml
penicillin
streptomycin
mm
ngml
dexamethason
vv
endotheli
cell
growth
microvascular
contain
lonza
walkersvil
md
cell
cultur
mgml
plate
plate
coat
ad
collagen
solut
well
h
rt
remov
rins
time
calcium
magnesium
free
pb
coat
plate
store
month
cell
kept
humidifi
incub
atmospher
liver
perfus
perform
femal
swiss
webster
mice
week
age
purchas
tacon
bioscienc
renssela
ny
mice
kept
free
environ
treat
accord
wadsworth
center
institut
anim
care
use
committe
guidelin
mice
euthan
asphyxi
follow
cervic
disloc
liver
perfus
inferior
vena
cava
cannul
x
close
iv
cathet
system
singl
port
bd
bioscienc
franklin
lake
nj
connect
syring
total
ml
preperfus
buffer
compos
gbss
without
calcium
appli
peristalt
pump
kd
scientif
holliston
flow
rate
mlmin
hepat
portal
vein
clip
allow
fluid
drainag
enzymat
digest
ml
perfus
buffer
consist
gbss
calcium
gml
type
iv
collagenas
thermo
fisher
pump
liver
mlmin
follow
digest
liver
excis
gall
bladder
remov
place
mm
cell
cultur
dish
contain
ml
wv
bsa
thermo
fisher
pb
without
mg
steril
hood
room
temperatur
primari
parenchym
nonparenchym
liver
cell
remov
liver
gentl
tear
shake
cell
suspens
pour
filter
conic
tube
step
repeat
cell
releas
conic
tube
fill
total
volum
ml
cell
suspens
subject
centrifug
min
time
remov
parenchym
cell
supernat
contain
nonparenchym
cell
store
ice
subsequ
step
perform
nonparenchym
cell
pellet
centrifug
min
rbc
lyse
incub
ml
ammonium
chlorid
stemcel
technolog
vancouv
canada
min
rbc
lysat
remov
ad
ml
centrifug
min
follow
parenchym
cell
rbc
remov
nonparenchym
cell
resuspend
ml
wv
cosmo
bio
usa
carlsbad
ca
conic
tube
layer
wv
gentli
layer
top
cell
centrifug
min
without
brake
cell
interfac
layer
ml
total
volum
care
remov
place
conic
tube
ad
final
volum
ml
cell
pellet
min
cell
resuspend
degass
mac
buffer
microbead
miltenyi
biotec
auburn
ca
ad
posit
select
kc
cell
bead
incub
min
dark
cell
wash
twice
ml
mac
buffer
resuspend
ml
mac
buffer
cell
separ
use
kit
miltenyi
biotec
presenc
magnet
field
column
hydrat
ml
mac
buffer
cell
suspens
ad
column
rins
ml
mac
buffer
elut
neg
select
cell
collect
conic
tube
posit
select
cell
retriev
remov
column
magnet
field
ad
ml
mac
buffer
plung
conic
tube
cell
seed
plate
imag
gather
phase
contrast
microscop
cell
seed
clear
plate
densiti
cellsml
ml
per
well
control
includ
unstain
cell
individu
stain
cell
kc
lsec
puriti
assess
cell
pellet
centrifug
min
resuspend
fc
block
solut
contain
trustain
fcxtm
antibodi
biolegend
san
diego
ca
dilut
swb
cell
incub
ice
min
block
solut
centrifug
min
cell
incub
conjug
primari
antibodi
dilut
swb
supplement
tabl
ice
min
bind
studi
cell
incub
ice
min
either
alon
lactos
mannan
mgml
mannan
lactos
plate
centrifug
min
cell
wash
twice
swb
final
plate
spun
min
cell
resuspend
swb
ml
falcon
tube
cell
analyz
immedi
bd
flow
cytomet
bd
bioscienc
cell
viabil
assess
ad
propidium
iodid
pi
stain
solut
fitc
annexin
v
apoptosi
detect
kit
ii
bd
pharmingen
san
diego
ca
unstain
control
white
plate
coat
type
rat
tail
collagen
mgml
thermo
fisher
scientif
dilut
pb
ricin
toxin
dose
optim
lsec
cell
seed
cellsml
kc
seed
cellsml
cell
treat
ricin
dilut
start
ngml
h
point
ricin
remov
cell
wash
hepe
buffer
regular
media
place
well
h
cell
viabil
assess
use
reagent
promega
madison
wi
spectramax
l
micropl
reader
molecular
devic
sunnyval
ca
h
puls
ricin
treatment
cell
treat
ricin
dilut
start
ngml
right
h
attach
period
cell
viabil
assess
h
later
rta
treatment
cell
seed
cellsml
treat
overnight
rta
dilut
start
ngml
treatment
perform
triplic
viabil
defin
averag
valu
obtain
well
cell
treat
sole
cell
medium
ricin
toxin
neutral
assay
murin
mab
vhh
follow
h
treatment
incorpor
ricin
dose
correspond
ricin
cytotox
curv
lsec
cell
treat
ngml
ricin
kc
treat
ngml
ricin
mab
titrat
well
contain
ricin
start
posit
control
cell
treat
pool
antisera
balbc
mice
hyperimmun
dose
respons
curv
cell
type
also
gener
antiserum
presenc
ricin
cell
viabil
assess
describ
cell
viabil
normal
cell
treat
medium
background
nois
reduc
subtract
averag
well
treat
ricin
dose
equival
valu
immulon
flat
bottom
microtit
plate
thermo
scientif
rochest
ny
coat
overnight
ricin
wash
pb
plu
vv
block
h
contain
vv
goat
serum
gibco
gaithersburg
md
sampl
prepar
separ
pvc
plate
serial
dilut
mannan
mix
recombin
mous
mr
r
system
minneapoli
mn
lsectin
r
system
concentr
equival
rel
valu
lsectin
mixtur
incub
h
rt
appli
microtit
plate
coat
ricin
duplic
incub
h
control
well
contain
mr
plate
wash
probe
tag
r
system
min
develop
inhibit
assay
serial
dilut
mab
start
separ
combin
mix
recombin
mous
mr
incub
h
rt
appli
microtit
plate
coat
ricin
describ
base
cytotox
result
h
puls
treatment
ricin
toxin
cell
seed
cellsml
plate
treat
ricin
dose
approxim
equal
valu
ricin
dose
curv
approxim
h
seed
lsec
kc
treat
ngml
ricin
cell
treat
ngml
ricin
h
concurr
cell
treat
either
mgml
yeast
lactos
thermo
fisher
mixtur
yeast
lactos
cell
viabil
assess
h
later
use
reagent
spectramax
l
micropl
reader
cell
viabil
normal
cell
treat
medium
background
nois
reduc
subtract
averag
well
treat
ricin
dose
equival
valu
mice
challeng
ip
iv
ricin
toxin
pb
premix
total
mab
control
includ
mice
treat
sole
ricin
toxin
pb
h
liver
perfus
cell
separ
kclsec
mixtur
use
densiti
gradient
centrifug
describ
flow
cytometri
perform
mixtur
assess
kc
deplet
treatment
group
experi
liver
spleen
harvest
analysi
use
immunohistochemistri
ihc
tissu
immers
allow
fix
buffer
formalin
h
subsequ
transfer
ethanol
prior
process
embed
tissu
section
stain
hematoxylin
eosin
histopatholog
evalu
tissu
section
thick
deparaffin
citrisolv
decon
lab
king
prussia
pa
rehydr
process
grade
alcohol
stain
antigen
retriev
perform
treat
tissu
section
proteinas
k
mgml
min
room
temperatur
antigen
retriev
cleav
perform
heat
slide
rodent
decloak
solut
biocar
medic
pacheco
ca
minut
use
rice
steamer
procedur
endogen
igg
nonspecif
background
block
rodent
block
biocar
medic
follow
alkalin
phosphatas
block
bloxal
vector
laboratori
stain
primari
ab
genetex
irvin
ca
incub
tissu
section
dilut
h
room
temperatur
subsequ
section
sequenti
incub
tissu
polym
biocar
medic
vina
green
chromogen
biocar
medic
stain
primari
ab
gene
tex
irvin
ca
incub
tissu
section
dilut
h
room
temperatur
subsequ
section
sequenti
incub
tissu
alkalin
polym
biocar
medic
contain
block
reagent
xm
factor
biocar
medic
fast
red
warp
red
biocar
medic
procedur
section
counterstain
tacha
hematoxylin
biocar
medic
mount
use
perman
mount
medium
ecomount
biocar
medic
statist
analysi
carri
graphpad
prism
graphpad
softwar
san
diego
ca
visual
perform
graphpad
prism
r
use
ggtheme
specif
detail
analysi
found
respect
figur
legend
studi
rat
mice
indic
kc
lsec
extrem
vulner
effect
ricin
better
understand
interact
ricin
toxin
cell
type
role
antibodi
may
play
protect
sought
establish
ex
vivo
model
primari
mous
kc
lsec
depict
fig
primari
kc
lsec
isol
liver
swiss
webster
mice
use
collagenas
perfus
method
cell
type
enrich
use
combin
centrifug
densiti
gradient
centrifug
magnet
magnet
separ
microbead
use
posit
select
mous
kc
lsec
collect
neg
select
known
univers
marker
cell
type
enabl
posit
although
numer
studi
report
use
magnet
microbead
lsec
select
strategi
captur
cell
reason
reli
neg
select
enrich
lsec
subset
assess
rel
enrich
primari
cell
popul
kc
lsec
pool
antibodi
specif
subject
flow
isol
purif
protocol
yield
kc
enrich
base
express
tabl
supplement
fig
kc
also
posit
data
shown
averag
kc
yield
per
mous
liver
cell
viabil
tabl
supplement
fig
lsec
pool
consist
subpopul
vari
express
level
tabl
supplement
fig
lsec
popul
describ
previous
subset
hepat
stellat
cell
hsc
vascular
endotheli
cell
cell
type
express
lsec
pool
also
contain
fraction
contamin
kc
viabil
lsec
base
trypan
blue
tb
pi
stain
tabl
supplement
fig
kc
lsec
popul
adher
microtit
plate
assum
morpholog
consist
kc
lsec
data
shown
next
examin
sensit
primari
kc
lsec
ricin
intox
cell
mous
macrophag
cell
line
report
express
mr
includ
control
ricin
cytotox
initi
evalu
across
rang
kc
lsec
densiti
cell
total
describ
section
materi
method
ultim
chose
total
cell
work
concentr
littl
variat
toxin
sensit
across
rang
cell
densiti
test
data
shown
depend
experi
perform
cytotox
profil
either
h
puls
ricin
prolong
h
incub
period
follow
seri
wash
step
remov
residu
extracellular
toxin
h
incub
kc
remark
sensit
effect
ricin
toxin
evidenc
valu
ngml
h
exposur
assay
respect
tabl
fig
cell
valu
ngml
h
exposur
respect
ricin
toxin
report
enter
bdmc
distinct
mechan
one
mediat
rtb
inhibit
lactos
mediat
mr
inhibit
flow
cytometri
confirm
isol
mous
kc
popul
posit
mr
supplement
fig
examin
contribut
pathway
ricin
uptak
kc
puls
h
ricin
presenc
satur
amount
exogen
lactos
mgml
lactos
kc
viabil
assess
h
later
neither
lactos
mannan
alon
abrog
effect
ricin
fig
howev
combin
lactos
mannan
afford
partial
protect
viabil
cell
death
consist
ricin
intern
kc
occur
via
rtb
mr
examin
factor
influenc
ricin
attach
kc
freshli
isol
cell
incub
puls
ricin
absenc
presenc
larg
excess
lactos
mannan
combin
lactos
mannan
cell
analyz
flow
cytometri
lactos
inhibit
ricin
bind
kc
wherea
mannan
alon
affect
attach
supplement
fig
combin
lactos
mannan
significantli
inhibit
bind
ricin
kc
beyond
lactos
alon
result
indic
vast
major
ricin
associ
kc
virtu
rtb
lectin
activ
wherea
mr
account
fraction
ricin
bind
howev
despit
differ
bind
pathway
appar
contribut
equal
ricin
uptak
neither
lactos
mannan
alon
impact
ricin
cytotox
kc
appar
disconnect
explain
fact
uptak
ineffici
wherea
mr
uptak
extrem
thu
even
small
amount
ricin
bound
mr
result
product
intox
cell
death
point
mannan
lactos
mixtur
partial
protect
kc
ricin
indic
exist
third
uptak
pathway
cell
although
investig
peptid
contain
ldv
sequenc
shown
trigger
apoptosi
huvec
via
process
inhibit
fibronectin
like
integrin
case
cell
lactos
alon
complet
inhibit
ricin
bind
cell
surfac
also
protect
cell
ricin
intox
fig
supplement
fig
mannan
affect
ricin
attach
cell
impact
ricin
cytotox
activ
thu
ricin
intox
cell
sole
depend
rtb
lectin
activ
even
though
cell
express
mr
surfac
supplement
fig
mr
express
report
vari
wide
among
differ
clone
possibl
explain
failur
mr
promot
ricin
uptak
next
examin
capac
mab
protect
kc
ricin
toxic
ex
vivo
previous
describ
collect
mab
rang
neutral
activ
vero
mab
direct
spatial
distinct
epitop
cluster
recogn
cluster
recogn
cluster
ii
mab
bind
cluster
iii
iv
respect
supplement
tabl
mechan
toxin
neutral
may
differ
depend
epitop
mab
epitop
cluster
ii
readili
neutral
ricin
cell
fig
mab
also
protect
kc
ricin
toxin
although
much
less
effect
cell
assay
fig
moreov
activ
plateau
kc
even
high
mab
concentr
also
afford
degre
activ
kc
fig
addit
individu
antibodi
abl
partial
protect
kc
ricin
less
effect
cytotox
assay
supplement
fig
comparison
purpos
overal
activ
mab
test
kc
assay
plot
area
curv
auc
fig
plot
illustr
superior
neutral
activ
mab
assay
compar
kc
assay
result
ex
vivo
studi
prompt
us
examin
degre
individu
mab
abl
protect
kc
vivo
chose
studi
repres
potent
class
ricin
inject
mice
ip
iv
rout
absenc
presenc
known
inject
ricin
mice
iv
ip
rout
result
toxin
accumul
mice
euthan
h
later
kc
isol
liver
describ
absenc
either
kc
popul
defin
stain
declin
consist
ricin
capac
essenti
ablat
cell
liver
fig
supplement
fig
loss
kc
situ
confirm
ihc
analysi
antibodi
fig
comparison
coadministr
ricin
result
complet
protect
kc
death
determin
flow
cytometri
ihc
ident
result
obtain
ricin
coadminist
deliv
mice
iv
inject
supplement
fig
thu
individu
mab
rta
rtb
abl
protect
kc
vivo
effect
ricin
exposur
even
though
afford
less
maxim
activ
ex
vivo
intervent
standpoint
singl
mab
like
would
consid
appropri
protect
kc
ricin
next
examin
sensit
lsec
ricin
shown
tabl
fig
ricin
induc
lsec
death
manner
estim
ngml
coadministr
ricin
either
lactos
mgml
afford
limit
protect
kill
wherea
combin
lactos
result
viabil
result
consist
ricin
uptak
lsec
occur
via
flow
cytometri
mr
express
detect
lsec
popul
popul
supplement
fig
collect
mab
evalu
abil
protect
lsec
effect
ricin
surprisingli
individu
mab
larg
complet
ineffect
neutral
ricin
lsec
cytotox
assay
fig
exampl
even
molar
excess
amount
afford
protect
ricin
kill
fig
two
mab
fare
slightli
better
viabil
never
achiev
complet
protect
failur
individu
mab
neutral
ricin
lsec
cytotox
assay
prompt
us
test
combin
mab
effect
creat
quadrival
cocktail
target
known
neutral
hotspot
rta
quadrival
ab
mixtur
demonstr
extrem
potent
activ
lsec
cytotox
assay
fig
effort
ascrib
neutral
activ
particular
mab
combin
differ
mab
test
possibl
combin
supplement
fig
certain
pair
name
afford
protect
high
concentr
mab
combin
achiev
potenc
observ
quadrival
cocktail
examin
combinatori
effect
antibodi
ricin
toxin
neutral
activ
lsec
cytotox
assay
turn
collect
singl
domain
antibodi
vhh
vhh
differ
convent
igg
mab
monoval
devoid
fc
element
therebi
elimin
contribut
aggreg
fcr
involv
cytotox
assay
vhh
target
rta
neutral
hotspot
test
individu
combin
although
individu
vhh
notabl
activ
quadrival
mixtur
prove
nearli
potent
inactiv
ricin
mab
cocktail
fig
thu
key
neutral
epitop
rta
rather
agglutin
uptak
like
respons
protect
lsec
effect
ricin
similar
pattern
emerg
test
collect
mous
igg
mab
alpaca
vhh
lsec
cytotox
assay
supplement
tabl
fig
neither
individu
mab
fig
individu
vhh
data
shown
demonstr
capac
neutral
ricin
lsec
assay
mixtur
combin
moder
activ
fig
next
obviou
line
investig
examin
activ
pair
mab
gener
differ
mab
combin
use
cocktail
demonstr
remark
potent
activ
evidenc
valu
fig
fact
profil
essenti
superimpos
indic
equal
potenc
achiev
irrespect
differ
epitop
target
rta
ie
cluster
ii
rtb
ie
domain
also
test
potenc
differ
pair
vhh
singl
chain
antibodi
two
differ
vhh
pair
demonstr
potent
activ
although
extent
observ
mab
fig
nonetheless
activ
associ
vhh
pair
much
greater
addit
effect
indic
target
ricin
subunit
simultan
result
synergist
activ
therefor
effect
mean
protect
lsec
ricin
hypothes
observ
synergi
mab
lsec
cytotox
assay
might
explain
mab
act
differ
ricin
uptak
pathway
base
literatur
postul
mab
block
uptak
pathway
wherea
mab
interfer
test
hypothesi
individu
mab
mix
lactos
block
uptak
mannan
block
mr
ctl
uptak
test
abil
protect
lsec
ricin
challeng
found
neutral
activ
mab
significantli
enhanc
addit
lactos
mannan
fig
exampl
lsec
viabil
presenc
ricin
wherea
addit
lactos
result
viabil
observ
mab
direct
epitop
cluster
ii
epitop
cluster
iii
overal
result
consist
mab
block
ricin
uptak
via
mr
anoth
ctl
lsec
cytotox
assay
lactos
uptak
pathway
unexpectedli
activ
mab
also
enhanc
lactos
exampl
addit
lactos
enhanc
activ
viabil
viabil
addit
mannan
enhanc
neutral
activ
viabil
fig
activ
also
enhanc
lactos
mannan
although
total
lsec
viabil
never
exceed
result
suggest
mab
may
also
interfer
ricin
uptak
via
mr
pathway
uptak
pathway
postul
fact
plu
lactos
much
effect
satur
amount
mannan
plu
lactos
protect
lsec
ricin
intox
indic
mab
effector
function
mimick
mannan
postul
plausibl
explan
simpli
bind
affin
exampl
bind
ricin
subnanomolar
affin
would
expect
stay
associ
ricin
follow
endocytosi
wherea
mannan
micromolar
affin
mr
would
expect
serv
rel
weak
competit
inhibitor
even
satur
dose
howev
stori
could
complic
complex
deliv
cytosol
actor
like
abl
promot
clearanc
immun
examin
possibl
mab
interfer
interact
establish
solid
phase
bind
assay
immobil
ricin
toxin
probe
recombin
mous
mr
interact
mr
immobil
ricin
inhibit
mannan
manner
fig
high
concentr
combin
partial
inhibit
reduct
bind
mr
ricin
also
affect
interact
lesser
extent
although
unclear
whether
reduct
bind
account
observ
effect
mab
activ
also
establish
bind
assay
ricin
lsectin
anoth
ctl
enrich
liver
recogn
glcnacman
residu
like
rta
lsectin
recogn
immobil
ricin
manner
although
neither
particularli
effect
block
interact
fig
collect
result
suggest
protect
lsec
ricin
toxin
mechan
interf
initi
recognit
ricin
mr
anoth
ctl
receptor
lsectin
rivax
recombin
rta
subunit
vaccin
shown
elicit
immun
ricin
mice
nonhuman
also
safe
human
administ
therefor
wish
examin
whether
antisera
abl
protect
kc
lsec
ex
vivo
ricin
incub
serial
dilut
rivax
vaccin
mice
appli
kc
lsec
found
similar
titer
eg
kc
lsec
consist
roughli
equal
degre
protect
supplement
fig
result
may
explain
part
rel
efficaci
rivax
vaccin
ricin
intox
liver
play
essenti
role
detoxif
clearanc
xenobiot
nonparenchym
cell
also
function
immun
surveil
uptak
report
investig
capac
mab
individu
combin
protect
primari
mous
kc
lsec
ricin
death
studi
motiv
fact
kc
lsec
notori
sensit
effect
ricin
point
recogn
decad
ago
rta
first
explor
inde
found
freshli
isol
mous
kc
time
sensit
ricin
standard
mous
cell
line
like
cell
nonetheless
individu
mab
rta
rtb
abl
protect
kc
ex
vivo
effici
similar
cell
addit
mab
abl
protect
kc
apoptosi
vivo
thu
despit
remark
sensit
ricin
toxin
kc
readili
protect
death
mab
lsec
anoth
stori
found
individu
mab
virtual
capac
protect
lsec
ricin
intox
exampl
even
shown
abl
rescu
rhesu
macaqu
lethal
dose
ricin
exposur
aerosol
afford
less
protect
lsec
kill
assay
shortcom
overcom
combin
mab
effect
combin
cocktail
target
rta
rtb
ie
although
pair
oligoclon
mixtur
equal
function
combin
vhh
monoval
lack
fc
element
also
neutral
activ
demonstr
neither
ricin
crosslink
aggreg
fcr
engag
necessari
protect
lsec
ricin
intox
consid
possibl
mechan
mab
protect
kc
lsec
import
keep
mind
ricin
uptak
cell
type
occur
least
distinct
pathway
one
inhibit
exogen
lactos
exogen
mannos
mannan
endocyt
pathway
studi
great
detail
mediat
rtb
affin
termin
galgalnac
residu
cell
surfac
glycoprotein
follow
endocytosi
ricin
holotoxin
traffick
retrograd
tgn
er
rta
liber
rtb
transloc
uptak
pathway
ineffici
howev
small
fraction
total
amount
ricin
bound
given
cell
surfac
actual
result
deliveri
rta
moreov
ricin
easili
derail
retrograd
transport
particularli
toxin
aggreg
complex
anoth
thing
consid
perhap
surpris
complex
recycl
ineffici
rout
uptak
pathway
exploit
ricin
intox
liver
cell
much
less
well
understood
although
uptak
histor
attribut
mr
assumpt
inconsist
demonstr
mr
mice
significantli
suscept
resist
death
moreov
lsec
sensit
ricin
toxin
even
though
mr
express
lsec
subset
total
popul
subset
therefor
plausibl
uptak
ricin
mediat
second
ctl
one
candid
lsectin
singl
domain
ctl
homolog
express
exclus
lsectin
serv
receptor
ebola
viru
sar
coronaviru
japanes
enceph
found
recombin
lsectin
recogn
ricin
toxin
solid
phase
bind
assay
interact
inhibit
mannan
assess
contribut
lsectin
promot
ricin
intox
lsec
vivo
await
test
lsectin
knockout
nevertheless
remain
unclear
ricin
evad
degrad
follow
uptak
lsec
cardin
featur
lsec
extraordinari
capac
degrad
endocytos
materi
includ
scaveng
receptor
like
mr
exampl
releas
cargo
within
acidifi
endosom
recycl
back
cell
cargo
destin
degrad
via
lysosom
proteolyt
process
load
onto
major
histocompat
complex
ricin
evad
fate
follow
uptak
mr
anoth
ctl
unknown
evid
ricin
pass
acid
compart
follow
uptak
via
pathway
ricin
known
mechan
breach
endocyt
similarli
complex
gener
studi
would
expect
taken
lsec
way
inhibitori
primarili
express
lsec
secondarili
kc
largest
contributor
clearanc
sic
circul
although
would
abl
intern
complex
eg
would
predict
engag
ricin
decor
mab
eg
rout
degrad
whether
play
role
clearanc
ricin
immun
complex
vivo
remain
determin
studi
add
grow
list
exampl
mab
cocktail
display
synergist
neutral
activ
well
beyond
achiev
singl
mab
case
botulinum
neurotoxin
bont
exampl
synergi
mab
cocktail
attribut
either
conform
chang
induc
ab
enhanc
secondari
ab
recognit
andor
toxin
case
staphylococcu
enterotoxin
b
seb
combin
mab
occlud
receptor
bind
site
mab
lesser
neutral
activ
enhanc
clearanc
seb
mous
model
similarli
combin
mab
shown
neutral
ebola
marburg
viru
anim
companion
studi
demonstr
cocktail
consist
far
superior
protect
am
tissu
resid
macrophag
death
vivo
compar
either
mab
individu
rong
et
al
manuscript
submit
am
hypersensit
effect
ricin
possibl
due
high
level
mr
success
studi
current
studi
prompt
us
gener
human
version
goal
test
combin
human
rhesu
macaqu
one
limit
studi
restrict
examin
liver
lsec
kc
essenti
ignor
effect
ricin
may
hepat
cellular
inflamm
physiolog
exampl
roch
colleagu
demonstr
mice
hepat
inflamm
patholog
follow
ricin
exposur
includ
influx
neutrophil
chemokin
express
eg
fibrin
deposit
red
blood
cell
congest
hepat
parenchyma
glycogen
obviou
metric
could
examin
context
mab
mab
cocktail
like
administ
concurr
timepoint
ricin
challeng
roch
colleagu
demonstr
mark
reduct
hepat
damag
addit
mab
mab
cocktail
